HEALTHCARE
HEMOSTATS MARKET GLOBAL FORECAST TO 2020
HEMOSTATS MARKET - GLOBAL FORECAST TO 2020
By Product Type (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), And Geography (Americas, Europe, Apac, Mea)
REPORT OVERVIEW 1.1
OBJECTIVES OF THE STUDY
•
When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding. The usage of hemostats must be quick, localized, and carefully regulated. Although, the usage of hemostats is not required until and unless the bleeding is heavy or the patient is suffering from congenital diseases or trauma defects.
•
Factors such as the size of the wound, bleeding severity, and its ease of use and application method are taken into consideration by the surgeons during the hemostasis. Hemostats are generally used in surgeries like laparoscopic, cardiovascular, and others.
•
On the basis of product type, the hemostats market has been segmented into thrombin based hemostats, oxidized regenerated cellulose based hemostats, gelatin based hemostats, combination hemostats, and collagen based hemostats. Of these product types, thrombin hemostats converts fibrinogen to fibrin, to initiate blood clot in the particular area of blood loss and this hemostats effectively controls minor bleeding from capillaries and small venules.
•
Oxidized regenerated cellulose based hemostats provides physical matrix to form blood clot and it has low pH, which has anti-microbial effect useful in order to prevent any side effects like swelling. This hemostats when used, enhances platelets adhesion and aggregation due to presence of poly anions.
•
Gelatin based hemostats is cheaper than other hemostats, mainly used in Asia-Pacific
sales@marketsandmarkets.com
www.marketsandmarkets.com
1
INTRODUCTION
and the Middle East & Africa. This hemostats are available in the form of sponges, which facilitates coagulation factors at the site of bleeding. •
Collagen based hemostats are absorbable and have microfibrillar collagen, prepared from purified bovine corium collagen found in every major tissue, which requires strength and flexibility, such as the skin, tendon, bone, and fascia. This hemostats enhances platelets formation.
•
Lastly, combination hemostats are basically the combination of gelatin and thrombin hemostats. This hemostats are costly and are majorly used in the U.S.
1.1
OBJECTIVES OF THE STUDY
1.2
•
To identify various types and usage patterns of hemostatic techniques across industries and analyze the complete ecosystem of the global hemostats market
•
To identify the market statistics with detailed classifications through the revenue generated by all the global players in the market
•
To analyze the influencing factors (drivers and restraints) of the global hemostats market
•
To analyze key market trends with regards to product type that impact the market growth
•
To segment the hemostats market by product and geography
•
To provide deep-dive analysis of the market segments and value forecast for the global hemostats market between 2015 and 2020
•
To provide a comprehensive competitive landscape and market share analysis of key market players
•
To profile key market players with respect to their product offerings, recent developments, and company financials
MARKET SEGMENTATION & COVERAGE
•
A detailed segmentation of the global hemostats market is illustrated in the figure below. • FIGURE 1
HEMOSTATS MARKET SEGMENTATION & COVERAGE •
MARKET SEGMENTATION
PRODUCT • Thrombin Based Hemostats • Combination Hemostats • Oxidized Regenerated Cellulose Based Hemostats • Gelatin Based Hemostats • Collagen Based Hemostats
•
GEOGRAPHY • • • •
Americas Europe Asia-Pacific Middle East and Africa
Source: Secondary Research, White Papers, Company Annual Reports, Press Releases, and MarketsandMarkets Analysis
sales@marketsandmarkets.com
www.marketsandmarkets.com
2
INTRODUCTION
1.3 STAKEHOLDERS •
Regulatory Authorities (such as FDA and insurance providers)
•
Biosurgery Product Manufacturers
•
Associations and International Bodies
•
Medical Device Companies
•
Research and Consulting Firms
•
Vendors and Service Providers
sales@marketsandmarkets.com
www.marketsandmarkets.com
3
RESEARCH METHODOLOGY
2
RESEARCH METHODOLOGY •
The MarketsandMarkets research methodology was used to arrive at the market size of the hemostats market. The research study involves extensive utilization of both primary and secondary sources. Primary sources include in-depth market insights acquired from several industry experts, preferred suppliers, distributors, manufacturers, service and reimbursement providers, technology developers, alliances, and organizations that are related to this industry’s value chain.
•
Primary research was conducted to critically analyze and identify the segmentation types, industry trends, and key companies thriving in this market. Secondary sources involve directories and databases, such as Bloomberg, Business Week, Factiva, Hoovers, and OneSource.
•
During the market engineering process (which includes calculations of market statistics, market crackdown, market size estimations, market forecast, and data triangulation), extensive research was conducted to gather information and validate the authenticity of data acquired.
•
Various approaches (which include top-down and macro indicator) were used for data triangulation methods while estimating the market size for the overall market segments and sub-segments listed in this report.
•
After validation of the market size across geography and various segments, an in-house multivariate forecasting model was used for the estimation of the market size for the period under consideration. The in-house multivariate model uses the qualitative information gathered from various secondary sources and industry experts along with quantitative variables to estimate the variation in market size for any specific year.
2.1
INTEGRATED ECOSYSTEM OF THE HEMOSTATS MARKET • FIGURE 2
HEMOSTATS MARKET: INTEGRATED ECOSYSTEM •
PARENT Healthcare Industry Medical Devices COMPANY
Wound Closure Devices
Johnson & Johnson Services, Inc. (Ethicon) C.R Bard (Davol, Inc.) Equimedical
HEMOSTATS
Gelita Medical Gmbh Marine Polymer Technologies, Inc.
•
Vascular Solutions, Inc.
PRODUCT TYPE
B. Braun Melsungen AG
Thrombin Based Hemostats
Baxter
Combination Hemostats
Pfizer Inc.
Oxidized Regenerated Cellulose Based Hemostats
Integra Lifesciences Holdings Corporation
Collagen Based Hemostats
Z-Medica, LLC
Gelatin Based Hemostats
Source: Secondary Research, White Papers, Company Annual Reports, Press Releases, and MarketsandMarkets Analysis
sales@marketsandmarkets.com
www.marketsandmarkets.com
4
RESEARCH METHODOLOGY
2.1.1 TOP-DOWN APPROACH •
The global wound closure devices market is segmented into sub-types like hemostats, sutures, surgical staples, tissue adhesive, sealants and glues, and others
•
Percentage share of hemostats in the global wound closure devices market, along with the market share of its peers was identified
•
Based on the percentage split, the global hemostats market was classified into 4 regions: the Americas, Europe, Asia-Pacific, and the Middle East and Africa (MEA)
• FIGURE 3
TOP-DOWN APPROACH
•
WOUND CLOSURE DEVICES MARKET 21.9%
Tissue Adhesive, Sealants and Glues
Surgical Staples
HEMOSTATS
Sutures
Others
Europe
Americas
Asia-Pacific
MEA
Germany
U.S.
China
Egypt
France
Canada
Japan
Saudi Arabia
U.K.
Mexico
India
Israel
Spain
Argentina
Republic of Korea (RoK)
Oman
Switzerland
Chile
Australia
Kuwait
Russia
Columbia
Thailand
Zimbabwe
The Netherlands
Uruguay
Taiwan
Kenya
Belgium
Paraguay
Malaysia
Jordan
Denmark
Indonesia
Algeria
Turkey
New Zealand
Morocco
Singapore
Libya Tunisia Sudan South Africa Mauritius
•
Source: Secondary Research, White Papers, Company Annual Reports, Press Releases, and MarketsandMarkets Analysis
sales@marketsandmarkets.com
www.marketsandmarkets.com
5
RESEARCH METHODOLOGY
2.1.2 BOTTOM-UP APPROACH •
The key players in the global hemostats market were identified
•
The company-wise revenues were identified
•
The revenue shares of the companies in the global hemostats market were identified
•
The summation of revenue shares of all the companies in the global hemostats segment was calculated
• FIGURE 4
BOTTOM-UP APPROACH Hemostats Market
•
Thrombin Based Hemostats
Combination Hemostats
Collagen Based Hemostats
Gelatin Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Johnson & Johnson Services, Inc. C R Bard, Inc. Baxter B Braun Melsungen AG Pfizer, Inc Vascular Solutions, Inc. Gelita Medical GmbH Equimedical Integra LifeSciences Holdings Corporation Company manufactures
•
Company does not manufacture
Source: Secondary Research, White Papers, Company Annual Reports, Press Releases, and MarketsandMarkets Analysis
2.1.3 MACRO INDICATOR- BASED APPROACH •
The macro indicator taken into consideration is healthcare expenditure
•
Total healthcare expenditure was derived on the global scale
•
Region-wise healthcare expenditure was derived from the global healthcare expenditure
•
Regional market size for hemostats was derived from the healthcare expenditures of the respective regions
•
The global hemostats market size was arrived by adding up market size of all the regions
sales@marketsandmarkets.com
www.marketsandmarkets.com
6
RESEARCH METHODOLOGY
2.1.4 UNIT PRICE ANALYSIS •
The average unit of different forms of hemostats was estimated based on the hemostats (quantity) required per surgery
•
The price per unit was arrived by taking the weighted average (sumproduct) of different forms of respective hemostats
• TABLE 1
UNIT PRICE ANALYSIS Forms
Hemostats
Collagen Based Thrombin Based
Sheet/Form
1 sheet/Foam irrespective of size
Flour
5gm
Powder
5000 IU (5ml) 1 Sheet irrespective of size
Sheet Oxidized Regenerated Cellulose Based
1 Sponge irrespective of size
Sponge
1 pad irrespective of size
Pad Gelatin Based Combination •
Unit
Powder
1gm
Sponge
1 Sponge irrespective of size
Powder and Diluent
5ml
Source: Secondary Research, White Papers, Company Annual Reports, Press Releases, and MarketsandMarkets Analysis
sales@marketsandmarkets.com
www.marketsandmarkets.com
7
RESEARCH METHODOLOGY
2.1.5 PRODUCT MATRIX •
ETHICON LLC (BY JOHNSON & JOHNSON SERVICES, INC.) •
SURGICEL SNoW® Absorbable Hemostat
•
SURGICEL® FIBRILLAR™ Absorbable Hemostat
•
SURGICEL NU-KNIT® Absorbable Hemostat
•
INSTAT® MCH Microfibrillar Collagen Hemostat
C. R. BARD, INC.
•
Arista™ AH
•
Avitene™ Microfibrillar Collagen Hemostat
•
Avitene™ Sheets
•
•
"SyringeAvitene™
•
FLOSEAL
•
Collagen Hemostat"
•
HEMOPATCH
•
SURGIFOAM® Absorbable Hemostat Family
•
ENDOAVITENE™ COLLAGEN HEMOSTAT
•
EVITHROM® Thrombin, Topical (Human)
•
•
SURGICEL Original Absorbable Hemostat
AVITENE™ ULTRAFOAM™ COLLAGEN SPONGE
B. BRAUN MELSUNGEN AG •
Sangustop®
•
Lyostypt®
•
Cellistypt®
•
Gelita
•
Bone Wax/Bone Wax Stick
BAXTER
PFIZER INC.
Gelfoam®
VASCULAR SOLUTIONS, INC.
•
D-Stat Dry Thrombix®
•
Gelfoam®
•
D-Stat Flowable
•
Thrombi-Pad™3x3 Hemostatic Pad
•
Vasc Band
•
D-Stat Radial
GELITA MEDICAL GMBH
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
EQUIMEDICAL •
Equicel®
•
GELITA-SPON®
•
Equispon®
•
Helistat®
•
GELITA-CEL®
•
Equitamp®
•
Helitene® Absorbable Collagen Hemostats
•
Equigen®
•
Interventional™ with 3M™ Tegaderm™ Bandage
•
QuikClot® Belt Trauma Kit™ (BTK)
•
QuikClot® Interventional™ Pre-Slit with 3M™ Tegaderm™ Bandage
•
Z-Medica® Hemorrhage Control Training Kit (with QuikClot Combat Gauze® LE)
•
QuikClot® EMS Rolled Gauze
Z-MEDICA, LLC •
QuikClot TraumaPad®
•
QuikClot® Roll
•
QuikClot® 4x4
•
QuikClot® Z-Fold
•
QuikClot®
Radial™
•
QuikClot®
QuikClot Combat Gauze® LE
•
QuikClot Combat Gauze® XL
•
QuikClot Combat Gauze®
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
8
RESEARCH METHODOLOGY
2.1.6 PORTER’S FIVE FORCES MODEL •
THREAT OF NEW ENTRANTS
THREAT OF SUBSTITUTES
Threat of new entrants is medium-to-high
Threat from substitutes is low, Availability of few substitute technologies for monitoring and data presentation
However, the entry barriers are high in module upgradation of the Hemostats devices market.
PORTER’S FIVE FORCE ANALYSIS
BARGAINING POWER OF SUPPLIERS
BARGAINING POWER OF BUYERS
Bargaining power of suppliers is medium
Bargaining power of buyers is medium
High degree of technological capabilities, coupled with a high buyer-to-seller ratio, increases their bargaining power
Switching cost for buyers is low and brand loyalty is not a major concern
INTENSITY OF RIVALRY
Large hospitals / corporate hospitals resort to bulk purchasing of equipment, thus increasing their bargaining power
The intensity of rivalry among players is medium They compete with each other to expand their shares There is increase in mergers and acquisitions to obtain patents of smaller players indicating a medium degree of rivalry among the existing players
•
Source: Secondary Research, Primary Research, and MarketsandMarkets Analysis
2.1.7 LIFE EXPECTANCY RATE • FIGURE 6
LIFE EXPECTANCY RATE
•
GROWTH
Americas
Europe Asia-Pacific Middle East and Africa
INTRODUCTION •
GROWTH
MATURITY
DECLINE
TIME
Source: Secondary Research, Primary Research, and MarketsandMarkets Analysis
• sales@marketsandmarkets.com
www.marketsandmarkets.com
9
RESEARCH METHODOLOGY
•
The global hemostats market has been divided into four major regions, namely, Asia-Pacific, Europe, the Americas, and the Middle East & Africa. The Americas and European markets are moving toward the maturity phase. The market in the Americas is growing due to the increasing number of surgeries and increasing number of hospitals and aged population.
•
The European market is growing due to the technological advancements and is dominated majorly by Ethicon LLC (by J&J) whereas the market in Asia-Pacific is growing mainly because of the increasing usage of various product types of hemostats.
•
The Middle East and African region is in introductory phase for the products like oxidised regenerative cellulose based hemostats and combined hemostats except for a few countries such as Israel, which have a moderate number of surgical procedures. Lack of rapid adoption of newer techniques, lack of insurance providers for this devices in the Middle East and African region are restraining the growth; however, the potential is immense.
2.2 ASSUMPTIONS PARAMETER
ASSUMPTION
Exchange Rates & Currency Conversion
All the revenues have been provided in the globally accepted currency of United States Dollar (USD). In order to convert various currencies to USD, average historical exchange rates were used for specified years. For the historical and current exchange rates required for currency conversion purpose, the OANDA website was used.
Pricing Data
Wherever the actual data was not available, retail prices of hemostats were considered.
Rounding-off
Percentages and values have been rounded-off, wherever necessary.
Base Year
The base year for this report is 2014.
Status Quo
All the macroeconomic conditions have been assumed to remain same during the forecast period.
sales@marketsandmarkets.com
www.marketsandmarkets.com
10
TABLE OF CONTENTS
1 INTRODUCTION.........................................................................................................................17 •
1.1
OBJECTIVES OF THE STUDY...........................................................................................................................................17
•
1.2
MARKET SEGMENTATION & COVERAGE.........................................................................................................................18
•
1.3 STAKEHOLDERS...............................................................................................................................................................18
2
RESEARCH METHODOLOGY.....................................................................................................19 •
•
2.1
INTEGRATED ECOSYSTEM OF THE HEMOSTATS MARKET.............................................................................................20
•
2.1.1
TOP-DOWN APPROACH................................................................................................................................21
•
2.1.2
BOTTOM-UP APPROACH..............................................................................................................................22
•
2.1.3
MACRO INDICATOR- BASED APPROACH.....................................................................................................22
•
2.1.4
UNIT PRICE ANALYSIS..................................................................................................................................23
•
2.1.5
PRODUCT MATRIX.........................................................................................................................................24
•
2.1.6
PORTER’S FIVE FORCES MODEL...................................................................................................................25
•
2.1.7
LIFE EXPECTANCY RATE...............................................................................................................................25
2.2 ASSUMPTIONS................................................................................................................................................................26
3
EXECUTIVE SUMMARY..............................................................................................................27
4
MARKET OVERVIEW..................................................................................................................28 •
4.1 INTRODUCTION...............................................................................................................................................................28
•
4.2
MARKET DRIVERS AND INHIBITORS...............................................................................................................................28
•
4.3
KEY MARKET DYNAMICS................................................................................................................................................28
5
HEMOSTATS MARKET, BY PRODUCT TYPE...............................................................................31 •
6
5.1 INTRODUCTION...............................................................................................................................................................32 •
5.1.1
THROMBIN BASED HEMOSTATS...................................................................................................................33
•
5.1.2
OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS........................................................................35
•
5.1.3
COMBINATION HEMOSTATS.........................................................................................................................36
•
5.1.4
GELATIN BASED HEMOSTATS.......................................................................................................................38
•
5.1.5
COLLAGEN BASED HEMOSTATS...................................................................................................................39
HEMOSTATS MARKET, BY GEOGRAPHY...................................................................................41 •
6.1 INTRODUCTION...............................................................................................................................................................42
•
6.2 AMERICAS.......................................................................................................................................................................43
sales@marketsandmarkets.com
www.marketsandmarkets.com
11
TABLE OF CONTENTS
•
•
•
6.2.1 U.S.................................................................................................................................................................45
•
6.2.2 CANADA.........................................................................................................................................................46
•
6.2.3 MEXICO.........................................................................................................................................................48
•
6.2.4 BRAZIL...........................................................................................................................................................49
•
6.2.5 ARGENTINA....................................................................................................................................................51
•
6.2.6 CHILE.............................................................................................................................................................52
•
6.2.7 COLOMBIA.....................................................................................................................................................54
•
6.2.8 PARAGUAY.....................................................................................................................................................55
•
6.2.9 URUGUAY......................................................................................................................................................57
6.3 EUROPE............................................................................................................................................................................58 •
6.3.1 GERMANY......................................................................................................................................................61
•
6.3.2 FRANCE.........................................................................................................................................................62
•
6.3.3 U.K.................................................................................................................................................................64
•
6.3.4 ITALY..............................................................................................................................................................65
•
6.3.5 SPAIN.............................................................................................................................................................67
•
6.3.6 RUSSIA..........................................................................................................................................................68
•
6.3.7 SWITZERLAND...............................................................................................................................................70
•
6.3.8
•
6.3.9 BELGIUM.......................................................................................................................................................73
•
6.3.10 DENMARK......................................................................................................................................................74
•
6.3.11 TURKEY..........................................................................................................................................................76
THE NETHERLANDS.......................................................................................................................................71
6.4 ASIA-PACIFIC..................................................................................................................................................................78 •
6.4.1 JAPAN............................................................................................................................................................80
•
6.4.2 CHINA............................................................................................................................................................82
•
6.4.3 INDIA..............................................................................................................................................................83
•
6.4.4 AUSTRALIA....................................................................................................................................................85
•
6.4.5
•
6.4.6 THAILAND......................................................................................................................................................88
•
6.4.7 SINGAPORE...................................................................................................................................................89
•
6.4.8 VIETNAM........................................................................................................................................................91
•
6.4.9 TAIWAN..........................................................................................................................................................92
REPUBLIC OF KOREA....................................................................................................................................86
sales@marketsandmarkets.com
www.marketsandmarkets.com
12
TABLE OF CONTENTS
•
7
•
6.4.10 MALAYSIA......................................................................................................................................................94
•
6.4.11 INDONESIA....................................................................................................................................................95
•
6.4.12
NEW ZEALAND...............................................................................................................................................97
6.5
MIDDLE EAST & AFRICA (MEA)......................................................................................................................................99
•
6.5.1 EGYPT..........................................................................................................................................................101
•
6.5.2
•
6.5.3 UAE..............................................................................................................................................................104
•
6.5.4 ISRAEL.........................................................................................................................................................106
•
6.5.5 OMAN..........................................................................................................................................................107
•
6.5.6 KUWAIT........................................................................................................................................................109
•
6.5.7 ZIMBABWE...................................................................................................................................................110
•
6.5.8 KENYA..........................................................................................................................................................112
•
6.5.9 JORDAN.......................................................................................................................................................113
•
6.5.10 ALGERIA.......................................................................................................................................................115
•
6.5.11 MOROCCO...................................................................................................................................................116
•
6.5.12 LIBYA...........................................................................................................................................................118
•
6.5.13 TUNISIA.......................................................................................................................................................119
•
6.5.14 SUDAN.........................................................................................................................................................121
•
6.5.15
•
6.5.16 MAURITIUS..................................................................................................................................................124
SAUDI ARABIA.............................................................................................................................................103
SOUTH AFRICA............................................................................................................................................122
COMPETITIVE LANDSCAPE.....................................................................................................126 •
7.1
COMPANY SHARE ANALYSIS........................................................................................................................................126
•
7.1.1 U.S...............................................................................................................................................................126
•
7.1.2 CANADA.......................................................................................................................................................126
•
7.1.3 BRAZIL.........................................................................................................................................................127
•
7.1.4 GERMANY....................................................................................................................................................128
•
7.1.5 FRANCE.......................................................................................................................................................128
•
7.1.6 U.K...............................................................................................................................................................129
•
7.1.7 CHINA..........................................................................................................................................................130
•
7.1.8 INDIA............................................................................................................................................................130
•
7.1.9 JAPAN..........................................................................................................................................................131
sales@marketsandmarkets.com
www.marketsandmarkets.com
13
TABLE OF CONTENTS
•
7.2
PRODUCT LAUNCHES...................................................................................................................................................132
•
7.3
MERGERS AND ACQUISITIONS.....................................................................................................................................133
•
7.4
COLLABORATIONS, JOINT AGREEMENTS & EXPANSIONS, PARTNERSHIPS...............................................................134
•
7.5
APPROVALS, ALLIANCES, RELOCATIONS & LICENSING, AND NEW BRAND STRATEGY.............................................134
8
HEMOSTATS MARKET, BY COMPANY.....................................................................................135 •
•
•
•
8.1
JOHNSON & JOHNSON SERVICES, INC........................................................................................................................135
•
8.1.1
BUSINESS OVERVIEW.................................................................................................................................135
•
8.1.2
KEY FINANCIALS.........................................................................................................................................135
•
8.1.3
PRODUCT AND SERVICE OFFERINGS.........................................................................................................136
•
8.1.4
RELATED DEVELOPMENTS..........................................................................................................................137
•
8.1.5
MNM VIEW..................................................................................................................................................137
8.2
C. R. BARD, INC.............................................................................................................................................................138
•
8.2.1
BUSINESS OVERVIEW.................................................................................................................................138
•
8.2.2
KEY FINANCIALS.........................................................................................................................................138
•
8.2.3
PRODUCT AND SERVICE OFFERINGS.........................................................................................................139
•
8.2.4
RELATED DEVELOPMENTS..........................................................................................................................139
•
8.2.5
MNM VIEW..................................................................................................................................................139
8.3 BAXTER..........................................................................................................................................................................140 •
8.3.1 OVERVIEW...................................................................................................................................................140
•
8.3.2
KEY FINANCIALS.........................................................................................................................................140
•
8.3.3
PRODUCT AND SERVICE OFFERINGS.........................................................................................................141
•
8.3.4
RELATED DEVELOPMENTS..........................................................................................................................141
•
8.3.5
MNM VIEW..................................................................................................................................................142
8.4
B. BRAUN MELSUNGEN AG...........................................................................................................................................143
•
8.4.1
BUSINESS OVERVIEW.................................................................................................................................143
•
8.4.2
KEY FINANCIALS.........................................................................................................................................143
•
8.4.3
PRODUCTS AND SERVICE OFFERINGS.......................................................................................................144
•
8.4.4
RECENT DEVELOPMENTS...........................................................................................................................145
•
8.4.5
MNM VIEW..................................................................................................................................................145
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
14
TABLE OF CONTENTS
•
•
•
•
•
•
8.5
PFIZER INC.....................................................................................................................................................................146
•
8.5.1
BUSINESS OVERVIEW.................................................................................................................................146
•
8.5.2
KEY FINANCIALS.........................................................................................................................................146
•
8.5.3
PRODUCTS AND SERVICE OFFERINGS.......................................................................................................147
•
8.5.4
RECENT DEVELOPMENTS...........................................................................................................................147
•
8.5.5
MNM VIEW..................................................................................................................................................147
8.6
VASCULAR SOLUTIONS, INC........................................................................................................................................148
•
8.6.1
BUSINESS OVERVIEW.................................................................................................................................148
•
8.6.2
KEY FINANCIALS.........................................................................................................................................148
•
8.6.3
PRODUCTS AND SERVICE OFFERINGS.......................................................................................................149
•
8.6.4
RECENT DEVELOPMENTS...........................................................................................................................150
•
8.6.5
MNM VIEW..................................................................................................................................................150
8.7
GELITA MEDICAL GMBH................................................................................................................................................151
•
8.7.1
BUSINESS OVERVIEW.................................................................................................................................151
•
8.7.2
PRODUCTS AND SERVICE OFFERINGS.......................................................................................................151
•
8.7.3
RECENT DEVELOPMENTS...........................................................................................................................151
•
8.7.4
MNM VIEW..................................................................................................................................................151
8.8 EQUIMEDICAL................................................................................................................................................................152 •
8.8.1
BUSINESS OVERVIEW.................................................................................................................................152
•
8.8.2
PRODUCTS AND SERVICE OFFERINGS.......................................................................................................152
•
8.8.3
MNM VIEW..................................................................................................................................................152
8.9
INTEGRA LIFESCIENCES HOLDINGS CORPORATION...................................................................................................153
•
8.9.1
BUSINESS OVERVIEW.................................................................................................................................153
•
8.9.2
KEY FINANCIALS.........................................................................................................................................153
•
8.9.3
PRODUCT AND SERVICE OFFERINGS.........................................................................................................154
•
8.9.4
MNM VIEW..................................................................................................................................................154
8.10
Z-MEDICA, LLC..............................................................................................................................................................155
•
8.10.1
BUSINESS OVERVIEW.................................................................................................................................155
•
8.10.2
PRODUCT AND SERVICE OFFERINGS.........................................................................................................155
•
8.10.3
RELATED DEVELOPMENTS..........................................................................................................................155
•
8.10.4
MNM VIEW..................................................................................................................................................155
sales@marketsandmarkets.com
www.marketsandmarkets.com
15
TABLE OF CONTENTS
•
8.11
MARINE POLYMER TECHNOLOGIES, INC.....................................................................................................................156
•
8.11.1
BUSINESS OVERVIEW.................................................................................................................................156
•
8.11.2
PRODUCT AND SERVICE OFFERINGS.........................................................................................................156
•
8.11.3
MNM VIEW..................................................................................................................................................156
9 APPENDIX................................................................................................................................157 •
9.1
CUSTOMIZATION OPTIONS...........................................................................................................................................157
•
9.1.1
REGULATORY FRAMEWORK..........................................................................................................................................157
•
9.1.2
IMPACT ANALYSIS.........................................................................................................................................................157
•
9.2
INTRODUCING RT: REAL TIME MARKET INTELLIGENCE...............................................................................................158
•
9.3
RELATED REPORTS........................................................................................................................................................159
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
16
LIST OF TABLES
• TABLE 1
UNIT PRICE ANALYSIS.......................................................................................................................................23
• TABLE 2
HEMOSTATS MARKET: DRIVERS AND INHIBITORS...........................................................................................28
• TABLE 3
HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN).................................................................28
• TABLE 4
HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN).......................................................................29
• TABLE 5
COLLAGEN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN).......................................29
• TABLE 6
THROMBIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN).......................................29
• TABLE 7
GELATIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)...........................................29
• TABLE 8
COMBINATION HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)..............................................30
• TABLE 9
OXIDIZED REGENERATION COLLAGEN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)............................................................................................................30
• TABLE 10
HEMOSTATS MARKET, BY PRODUCT TYPE, 2013 – 2020 (USD MN)..............................................................32
• TABLE 11
HEMOSTATS MARKET, BY PRODUCT TYPE, 2013–2020 (UNITS)....................................................................33
• TABLE 12
THROMBIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013–2020 (USD MN)......................................34
• TABLE 13
THROMBIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013 – 2020 (UNITS)........................................34
• TABLE 14
OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013–2020 (USD MN)...........................................................................................................35
• TABLE 15
OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013 – 2020 (UNITS).............................................................................................................36
• TABLE 16
COMBINATION HEMOSTATS MARKET, BY GEOGRAPHY, 2013–2020 (USD MN).............................................37
• TABLE 17
COMBINATION HEMOSTATS MARKET, BY GEOGRAPHY, 2013 – 2020 (UNITS)...............................................37
• TABLE 18
GELATIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013–2020 (USD MN)...........................................38
• TABLE 19
GELATIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013 – 2020 (UNITS)............................................39
• TABLE 20
COLLAGEN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013–2020 (USD MN)......................................40
• TABLE 21
COLLAGEN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013 – 2020 (UNITS)........................................40
• TABLE 22
HEMOSTATS MARKET, BY REGION, 2013-2020 (USD MN)..............................................................................42
• TABLE 23
AMERICAS HEMOSTATS MARKET, BY COUNTRY, 2013-2020 (USD MN).........................................................44
• TABLE 24
AMERICAS HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)..............................................44
• TABLE 25
U.S. HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN).........................................................45
• TABLE 26
U.S. HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS).............................................................45
• TABLE 27
U.S. HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD).....................46
• TABLE 28
CANADA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)..................................................47
sales@marketsandmarkets.com
www.marketsandmarkets.com
17
LIST OF TABLES
• TABLE 29
CANADA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)......................................................47
• TABLE 30
CANADA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)..............47
• TABLE 31
MEXICO HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)...................................................48
• TABLE 32
MEXICO HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)......................................................48
• TABLE 33
MEXICO HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)..............49
• TABLE 34
BRAZIL HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)....................................................49
• TABLE 35
BRAZIL HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)........................................................50
• TABLE 36
BRAZIL HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)................50
• TABLE 37
ARGENTINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN).............................................51
• TABLE 38
ARGENTINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS).................................................51
• TABLE 39
ARGENTINA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD).........52
• TABLE 40
CHILE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)......................................................52
• TABLE 41
CHILE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)..........................................................53
• TABLE 42
CHILE HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)..................53
• TABLE 43
COLOMBIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)..............................................54
• TABLE 44
COLOMBIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)..................................................54
• TABLE 45
COLOMBIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)..........55
• TABLE 46
PARAGUAY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)..............................................55
• TABLE 47
PARAGUAY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)..................................................56
• TABLE 48
PARAGUAY HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)..........56
• TABLE 49
URUGUAY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)................................................57
• TABLE 50
URUGUAY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)...................................................57
• TABLE 51
URUGUAY HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)...........58
• TABLE 52
EUROPE HEMOSTATS MARKET, BY COUNTRY, 2013-2020 (USD MN).............................................................59
• TABLE 53
EUROPE HEMOSTATS MARKET VALUE, BY PRODUCT TYPE, 2013-2020 (USD MN)......................................60
• TABLE 54
GERMANY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)...............................................61
• TABLE 55
GERMANY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)...................................................61
• TABLE 56
GERMANY HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)...........62
• TABLE 57
FRANCE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)...................................................62
• TABLE 58
FRANCE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)......................................................63
sales@marketsandmarkets.com
www.marketsandmarkets.com
18
LIST OF TABLES
• TABLE 59
FRANCE HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)..............63
• TABLE 60
U.K. HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN).........................................................64
• TABLE 61
U.K. HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS).............................................................64
• TABLE 62
U.K. HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD).....................65
• TABLE 63
ITALY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN).......................................................65
• TABLE 64
ITALY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)...........................................................66
• TABLE 65
ITALY HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)...................66
• TABLE 66
SPAIN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)......................................................67
• TABLE 67
SPAIN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)..........................................................67
• TABLE 68
SPAIN HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)..................68
• TABLE 69
RUSSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)....................................................68
• TABLE 70
RUSSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS).......................................................69
• TABLE 71
RUSSIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)...............69
• TABLE 72
SWITZERLAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)........................................70
• TABLE 73
SWITZERLAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)............................................70
• TABLE 74
SWITZERLAND HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD).............................................................................................................71
• TABLE 75
THE NETHERLANDS HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)................................71
• TABLE 76
THE NETHERLANDS HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)....................................72
• TABLE 77
THE NETHERLANDS HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD).............................................................................................................72
• TABLE 78
BELGIUM HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN).................................................73
• TABLE 79
BELGIUM HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)....................................................73
• TABLE 80
BELGIUM HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)............74
• TABLE 81
DENMARK HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)...............................................74
• TABLE 82
DENMARK HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)...................................................75
• TABLE 83
DENMARK HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)...........75
• TABLE 84
TURKEY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)...................................................76
• TABLE 85
TURKEY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS).......................................................76
• TABLE 86
TURKEY HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)...............77
• TABLE 87
ASIA-PACIFIC HEOMSTATS MARKET, BY COUNTRY, 2013-2020 (USD MN)....................................................79
sales@marketsandmarkets.com
www.marketsandmarkets.com
19
LIST OF TABLES
• TABLE 88
ASIA-PACIFIC HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)..........................................80
• TABLE 89
JAPAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN).....................................................80
• TABLE 90
JAPAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS).........................................................81
• TABLE 91
JAPAN HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD).................81
• TABLE 92
CHINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN).....................................................82
• TABLE 93
CHINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS).........................................................82
• TABLE 94
CHINA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD).................83
• TABLE 95
INDIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN).......................................................83
• TABLE 96
INDIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)...........................................................84
• TABLE 97
INDIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)...................84
• TABLE 98
AUSTRALIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN).............................................85
• TABLE 99
AUSTRALIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS).................................................85
• TABLE 100
AUSTRALIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD).........86
• TABLE 101
REPUBLIC OF KOREA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)..............................87
• TABLE 102
REPUBLIC OF KOREA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS).................................87
• TABLE 103
REPUBLIC OF KOREA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD).............................................................................................................87
• TABLE 104
THAILAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)...............................................88
• TABLE 105
THAILAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)...................................................88
• TABLE 106
THAILAND HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)...........89
• TABLE 107
SINGAPORE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN).............................................90
• TABLE 108
SINGAPORE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)................................................90
• TABLE 109
SINGAPORE HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)........90
• TABLE 110
VIETNAM HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN).................................................91
• TABLE 111
VIETNAM HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS).....................................................91
• TABLE 112
VIETNAM HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD).............92
• TABLE 113
TAIWAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)...................................................92
• TABLE 114
TAIWAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS).......................................................93
• TABLE 115
TAIWAN HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)...............93
• TABLE 116
MALAYSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)...............................................94
• TABLE 117
MALAYSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)...................................................94
sales@marketsandmarkets.com
www.marketsandmarkets.com
20
LIST OF TABLES
• TABLE 118
MALAYSIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)...........95
• TABLE 119
INDONESIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)..............................................95
• TABLE 120
INDONESIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS).................................................96
• TABLE 121
INDONESIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD).........96
• TABLE 122
NEW ZEALAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)........................................97
• TABLE 123
NEW ZEALAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)............................................97
• TABLE 124
NEW ZEALAND HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD).............................................................................................................98
• TABLE 125
MIDDLE EAST & AFRICA HEMOSTATS MARKET, BY COUNTRY, 2013-2020 (USD MN).................................100
• TABLE 126
MIDDLE EAST & AFRICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)......................101
• TABLE 127
EGYPT HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)...................................................101
• TABLE 128
EGYPT HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS).......................................................102
• TABLE 129
EGYPT HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)...............102
• TABLE 130
SAUDI ARABIA HEMOSTATS, BY PRODUCT TYPE, 2013-2020 (USD MN).....................................................103
• TABLE 131
SAUDI ARABIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)..........................................103
• TABLE 132
SAUDI ARABIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)...........................................................................................................104
• TABLE 133
UAE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN).......................................................105
• TABLE 134
UAE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)...........................................................105
• TABLE 135
UAE HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)...................105
• TABLE 136
ISRAEL HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)..................................................106
• TABLE 137
ISRAEL HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)......................................................106
• TABLE 138
ISRAEL HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)..............107
• TABLE 139
OMAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)....................................................107
• TABLE 140
OMAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS).......................................................108
• TABLE 141
OMAN HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)...............108
• TABLE 142
KUWAIT HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN).................................................109
• TABLE 143
KUWAIT HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS).....................................................109
• TABLE 144
KUWAIT HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD).............110
• TABLE 145
ZIMBABWE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)............................................110
• TABLE 146
ZIMBABWE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)................................................111
sales@marketsandmarkets.com
www.marketsandmarkets.com
21
LIST OF TABLES
• TABLE 147
ZIMBABWE HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)........111
• TABLE 148
KENYA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)...................................................112
• TABLE 149
KENYA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS).......................................................112
• TABLE 150
KENYA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)...............113
• TABLE 151
JORDAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)................................................113
• TABLE 152
JORDAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)....................................................114
• TABLE 153
JORDAN HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)............114
• TABLE 154
ALGERIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)................................................115
• TABLE 155
ALGERIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)....................................................115
• TABLE 156
ALGERIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)............116
• TABLE 157
MOROCCO HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)............................................116
• TABLE 158
MOROCCO HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)................................................117
• TABLE 159
MOROCCO HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)........117
• TABLE 160
LIBYA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN).....................................................118
• TABLE 161
LIBYA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)........................................................118
• TABLE 162
LIBYA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)................119
• TABLE 163
TUNISIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN).................................................119
• TABLE 164
TUNISIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)....................................................120
• TABLE 165
TUNISIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)............120
• TABLE 166
SUDAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)..................................................121
• TABLE 167
SUDAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)......................................................121
• TABLE 168
SUDAN HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)..............122
• TABLE 169
SOUTH AFRICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN).....................................122
• TABLE 170
SOUTH AFRICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS).........................................123
• TABLE 171
SOUTH AFRICA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)...........................................................................................................123
• TABLE 172
MAURITIUS HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)...........................................124
• TABLE 173
MAURITIUS HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)...............................................124
• TABLE 174
MAURITIUS HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)...........................................................................................................125
• TABLE 175
HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)....................................................................126
sales@marketsandmarkets.com
www.marketsandmarkets.com
22
LIST OF TABLES
• TABLE 176
CANADA HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)....................................................127
• TABLE 177
BRAZIL HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%).......................................................127
• TABLE 178
GERMANY HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)..................................................128
• TABLE 179
FRANCE HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%).....................................................129
• TABLE 180
U.K. HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)............................................................129
• TABLE 181
CHINA HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)........................................................130
• TABLE 182
INDIA HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%).........................................................131
• TABLE 183
JAPAN HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014...............................................................131
• TABLE 184
PRODUCT LAUNCHES.....................................................................................................................................132
• TABLE 185
MERGERS AND ACQUISITIONS.......................................................................................................................133
• TABLE 186
COLLABORATIONS, JOINT AGREEMENTS & EXPANSIONS, PARTNERSHIPS.................................................134
• TABLE 187
APPROVALS, ALLIANCES, RELOCATION & LICENSING, AND NEW BRAND STRATEGY.................................134
• TABLE 188
JOHNSON & JOHNSON SERVICES, INC.: REVENUE, BY BUSINESS SEGMENT, 2011-2014 (USD MN)........135
• TABLE 189
JOHNSON & JOHNSON SERVICES, INC.: REVENUE, BY GEOGRAPHIC SEGMENT, 2011-2014 (USD MN)....................................................................................................................136
• TABLE 190
C. R. BARD, INC.: REVENUE, BY BUSINESS SEGMENTS, 2010-2014 (USD MN)...........................................138
• TABLE 191
BAXTER: REVENUE, BY BUSINESS SEGMENTS, 2010-2014 (USD MN).........................................................140
• TABLE 192
BAXTER: REVENUE, BY GEOGRAPHIC SEGMENT, 2010-2014 (USD MN)......................................................141
• TABLE 193
B. BRAUN MELSUNGEN AG: REVENUE, BY BUSINESSS SEGMENT, 2010-2014 (USD MN)..........................143
• TABLE 194
B. BRAUN MELSUNGEN AG: REVENUE, BY GEOGRAPHIC SEGMENT,2010-2014 (USD MN)........................144
• TABLE 195
PFIZER INC.: REVENUE MIX, 2010-2014 (USD MN).......................................................................................146
• TABLE 196
PFIZER INC.: REVENUE, BY GEOGRAPHIC SEGMENT 2010-2014 (USD MN).................................................146
• TABLE 197
VASCULAR SOLUTIONS, INC.: REVENUE, BY SEGMENT, 2010-2014 (USD MN)...........................................148
• TABLE 198
VASCULAR SOLUTIONS, INC.: REVENUE, BY GEOGRAPHIC SEGMENT, 2010-2014 (USD MN)....................149
• TABLE 199
INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE, BY BUSINESS SEGMENT, 2011 - 2014 (USD MN)..........................................................................................153
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
23
LIST OF FIGURES
• FIGURE 1
HEMOSTATS MARKET SEGMENTATION & COVERAGE.....................................................................................18
• FIGURE 2
HEMOSTATS MARKET: INTEGRATED ECOSYSTEM...........................................................................................20
• FIGURE 3
TOP-DOWN APPROACH....................................................................................................................................21
• FIGURE 4
BOTTOM-UP APPROACH..................................................................................................................................22
• FIGURE 5
MACRO INDICATOR-BASED APPROACH..........................................................................................................23
• FIGURE 6
LIFE EXPECTANCY RATE...................................................................................................................................25
• FIGURE 7
HEMOSTATS MARKET SNAPSHOT 2014...........................................................................................................27
• FIGURE 8
HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)..............................................................32
• FIGURE 9
THROMBIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2015 & 2020 (USD MN)....................................33
• FIGURE 10
OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2015 & 2020 (USD MN).........................................................................................................35
• FIGURE 11
COMBINATION HEMOSTATS MARKET, BY GEOGRAPHY, 2015 & 2020 (USD MN)..........................................36
• FIGURE 12
GELATIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2015 & 2020 (USD MN)........................................38
• FIGURE 13
COLLAGEN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2015 & 2020 (USD MN)....................................39
• FIGURE 14
HEMOSTATS MARKET, BY REGION, 2015 & 2020 (USD MN)...........................................................................42
• FIGURE 15
AMERICAS HEMOSTATS MARKET, BY COUNTRY, 2014 & 2020 (USD MN).....................................................43
• FIGURE 16
AMERICAS HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)...........................................44
• FIGURE 17
U.S. HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)......................................................45
• FIGURE 18
CANADA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)...............................................46
• FIGURE 19
MEXICO HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)...............................................48
• FIGURE 20
BRAZIL HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN).................................................49
• FIGURE 21
ARGENTINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)..........................................51
• FIGURE 22
CHILE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)...................................................52
• FIGURE 23
COLOMBIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)...........................................54
• FIGURE 24
PARAGUAY HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)...........................................55
• FIGURE 25
URUGUAY HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)............................................57
• FIGURE 26
EUROPE HEMOSTATS MARKET, BY COUNTRY, 2014 & 2020 (USD MN)..........................................................59
• FIGURE 27
EUROPE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)...............................................60
• FIGURE 28
GERMANY HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)............................................61
• FIGURE 29
FRANCE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)...............................................62
• FIGURE 30
U.K. HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)......................................................64
sales@marketsandmarkets.com
www.marketsandmarkets.com
24
LIST OF FIGURES
• FIGURE 31
ITALY HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)....................................................65
• FIGURE 32
SPAIN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)...................................................67
• FIGURE 33
RUSSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)................................................68
• FIGURE 34
SWITZERLAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN).....................................70
• FIGURE 35
THE NETHERLANDS HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN).............................71
• FIGURE 36
BELGIUM HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN).............................................73
• FIGURE 37
DENMARK HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)............................................74
• FIGURE 38
TURKEY HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)................................................76
• FIGURE 39
ASIA-PACIFIC HEMOSTATS MARKET, BY COUNTRY, 2014 & 2020 (USD MN)................................................78
• FIGURE 40
ASIA-PACIFIC HEMOSTATS MARKET VALUE, BY PRODUCT TYPE, 2015 & 2020 (USD MN)..........................79
• FIGURE 41
JAPAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)..................................................80
• FIGURE 42
CHINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)..................................................82
• FIGURE 43
INDIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)....................................................83
• FIGURE 44
AUSTRALIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)..........................................85
• FIGURE 45
REPUBLIC OF KOREA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)..........................86
• FIGURE 46
THAILAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)............................................88
• FIGURE 47
SINGAPORE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN).........................................89
• FIGURE 48
VIETNAM HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)..............................................91
• FIGURE 49
TAIWAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)................................................92
• FIGURE 50
MALAYSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)............................................94
• FIGURE 51
INDONESIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)..........................................95
• FIGURE 52
NEW ZEALAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN).....................................97
• FIGURE 53
MIDDLE EAST & AFRICA HEMOSTATS MARKET, BY COUNTRY, 2014 & 2020 (USD MN)...............................99
• FIGURE 54
MIDDLE EAST & AFRICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)...................100
• FIGURE 55
EGYPT HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)................................................101
• FIGURE 56
SAUDI ARABIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)...................................103
• FIGURE 57
UAE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)....................................................104
• FIGURE 58
ISRAEL HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)...............................................106
• FIGURE 59
OMAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)................................................107
• FIGURE 60
KUWAIT HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)..............................................109
• FIGURE 61
ZIMBABWE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN).........................................110
sales@marketsandmarkets.com
www.marketsandmarkets.com
25
LIST OF FIGURES
• FIGURE 62
KENYA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)................................................112
• FIGURE 63
JORDAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN).............................................113
• FIGURE 64
ALGERIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN).............................................115
• FIGURE 65
MOROCCO HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN).........................................116
• FIGURE 66
LIBYA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN).................................................118
• FIGURE 67
TUNISIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN).............................................119
• FIGURE 68
SUDAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)...............................................121
• FIGURE 69
SOUTH AFRICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)..................................122
• FIGURE 70
MAURITIUS HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)...........................................124
• FIGURE 71
U.S. HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)............................................................126
• FIGURE 72
CANADA HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)....................................................126
• FIGURE 73
BRAZIL HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%).......................................................127
• FIGURE 74
GERMANY HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)..................................................128
• FIGURE 75
FRANCE HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%).....................................................128
• FIGURE 76
U.K. HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)............................................................129
• FIGURE 77
CHINA HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)........................................................130
• FIGURE 78
INDIA HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%).........................................................130
• FIGURE 79
JAPAN HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)........................................................131
• FIGURE 80
JOHNSON & JOHNSON SERVICES, INC: REVENUE MIX, 2014 (%)................................................................135
• FIGURE 81
JOHNSON & JOHNSON SERVICES, INC.: REVENUE MIX, 2014 (%)...............................................................136
• FIGURE 82
C. R. BARD, INC.: REVENUE MIX, 2014 (%)....................................................................................................138
• FIGURE 83
BAXTER: REVENUE MIX, 2014 (%)..................................................................................................................140
• FIGURE 84
BAXTER: REVENUE MIX, 2010-2014 (%)........................................................................................................141
• FIGURE 85
B. BRAUN MELSUNGEN AG: REVENUE MIX, 2014 (%)...................................................................................143
• FIGURE 86
B. BRAUN MELSUNGEN AG.: REVENUE MIX, 2014 (%)..................................................................................144
• FIGURE 87
PFIZER INC.: -REVENUE MIX, 2014 (%)..........................................................................................................146
• FIGURE 88
VASCULAR SOLUTIONS, INC.: REVENUE MIX, 2014 (%)...............................................................................148
• FIGURE 89
VASCULAR SOLUTIONS, INC.: REVENUE MIX, 2014 (%)...............................................................................149
• FIGURE 90
INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE MIX, 2014 (%)...........................................153
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
26
SAMPLE TABLES
TABLE 1
COMBINATION HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN) 2013
2014
2015
2020
CAGR (2015-2020)
Americas
xx.x
xx.x
xx.x
xx.x
xx.x%
Europe
xx.x
xx.x
xx.x
xx.x
xx.x%
Asia-Pacific
xx.x
xx.x
xx.x
xx.x
xx.x%
Middle East & Africa
xx.x
xx.x
xx.x
xx.x
xx.x%
TOTAL
xx.x
xx.x
xx.x
xx.x
xx.x%
REGION
Source: Secondary Research, White Papers, Company Annual Reports, Press Releases, and MarketsandMarkets Analysis
TABLE 2 HEMOSTATS MARKET, BY PRODUCT TYPE, 2013 – 2020 (USD MN) 2013
2014
2015
2020
CAGR (2015-2020)
Thrombin Based Hemostats
xx.x
xx.x
xx.x
xx.x
xx.x%
Combination Hemostats
xx.x
xx.x
xx.x
xx.x
xx.x%
Oxidized Regenerated Cellulose Based Hemostats
xx.x
xx.x
xx.x
xx.x
xx.x%
Gelatin Based Hemostats
xx.x
xx.x
xx.x
xx.x
xx.x%
Collagen Based Hemostats
xx.x
xx.x
xx.x
xx.x
xx.x%
TOTAL
xx.x
xx.x
xx.x
xx.x
xx.x%
PRODUCT TYPE
Sources: Secondary Research, White Papers, Company Annual Reports, Press Releases, and MarketsandMarkets Analysis
TABLE 3
XIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET, O BY GEOGRAPHY, 2013–2020 (UNITS) 2013
2014
2015
2020
CAGR (2015-2020)
Americas
xx.x
xx.x
xx.x
xx.x
xx.x%
Europe
xx.x
xx.x
xx.x
xx.x
xx.x%
Asia-Pacific
xx.x
xx.x
xx.x
xx.x
xx.x%
Middle East and Africa
xx.x
xx.x
xx.x
xx.x
xx.x%
TOTAL
xx.x
xx.x
xx.x
xx.x
xx.x%
REGION
Sources: Secondary Research, White Papers, Company Annual Reports, Press Releases, and MarketsandMarkets Analysis
sales@marketsandmarkets.com
www.marketsandmarkets.com
27
RELATED REPORTS
RELATED REPORTS SR. NO.
REPORT TITLE
PUBLISHED DATE
1
BIOSURGERY MARKET by Type (Surgical Sealants, Hemostatic Agents, Soft Tissue Attachments, Adhesion Barriers, Bone Graft Substitutes), Application (Neurological, Cardiovascular, General, Orthopedic, Reconstructive) - Global Forecast to 2020
June 2015
2
SURGICAL SEALANTS AND ADHESIVES MARKET by Product (Natural & Synthetic, Fibrin, Collagen, Gelatin, Cyanoacrylate, Polymeric, Polyurethane), & Application (CNS, Orthopedic, Cardiovascular, Cosmetic Surgery) - Global Forecast to 2020
June 2015
H
ET
ARK
TS M
STA EMO
0
ON,
202
ATI MBIN , CO ) EA LOSE ELLU APAC, M DC , ERATE ROPE G EGEN ICAS, EU R IDISED Y (AMER , OX PH MBIN EOGRA HRO PE (T ), AND G CT TY EN ODU OLLAG PR C BY , ATIN GEL
AL LOB
ST TO
ECA
FOR
m
ts.co
arke
ndm
etsa
mark
s@ sale
.com
rkets
dma
tsan
arke
.m www
sales@marketsandmarkets.com
www.marketsandmarkets.com
28
ABOUT MNM
MarketsandMarkets is a global market research and consulting company based in the U.S. It is World’s No. 2 in terms of premium market research studies published annually. Serving as a business intelligence partner to Fortune 500 companies across the world, it provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers seventeen industry verticals, including advanced materials, aerospace and defense, agriculture, automotive and transportation, biotechnology, building and construction, chemicals, energy and power, food and beverages, industrial automation, medical devices, mining, minerals and metals, packaging, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
Copyright © 2016 MarketsandMarkets All Rights Reserved. This document contains highly confidential information and is the sole property of MarketsandMarkets. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of MarketsandMarkets.
DISCLAIMER: MarketsandMarkets strategic analysis services are limited publications containing valuable market information provided to a select group of customers in response to orders. Our customers acknowledge, when ordering, that MarketsandMarkets strategic analysis services are for our customers’ internal use and not for general publication or disclosure to third parties. Quantitative market information is based primarily on interviews and therefore, is subject to fluctuation. MarketsandMarkets does not endorse any vendor, product or service depicted in its research publications. MarketsandMarkets strategic analysis publications consist of the opinions of MarketsandMarkets’ research and should not be construed as statements of fact. MarketsandMarkets disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. MarketsandMarkets takes no responsibility for any incorrect information supplied to us by manufacturers or users. All trademarks, copyrights and other forms of intellectual property belong to their respective owners and may be protected by copyright. Under no circumstance may any of these be reproduced in any form without the prior written agreement of their owner. No part of this strategic analysis service may be given, lent, resold or disclosed to non-customers without written permission. Reproduction and/or transmission in any form and by any means including photocopying, mechanical, electronic, recording or otherwise, without the permission of the publisher is prohibited.
For information regarding permission, contact: 1-888-600-6441 sales@marketsandmarkets.com
sales@marketsandmarkets.com
www.marketsandmarkets.com
29